Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Recurrent astrocyte transcriptional states with spatial and functional specialization are induced by brain metastases independently of their primary tumor origin

Reactive astrocytes have emerged as important components of the brain metastasis niche, yet a state-resolved framework for metastasis-associated astrocyte biology is still lacking. Here, we integrate single-cell and spatial transcriptomics across syngeneic breast, lung and melanoma models of brain metastases to define a state-resolved astrocyte landscape. We identify recurrent tumor-associated…

Reactive astrocytes, previously considered mere bystanders in brain metastasis, now reveal their crucial role in the tumor microenvironment. Through the integration of single-cell and spatial transcriptomics, we have created a state-resolved framework for astrocyte biology within brain metastases. We discovered recurrent tumor-associated astrocyte states that remain consistent across different primary tumor types, such as breast, lung, and melanoma.

These shared states are distributed spatially within the metastatic brain, suggesting a niche-coupled organization rather than a diffuse inflammatory response.

Among these tumor-associated states, a subset named AST-BrM exhibits selective reprogramming at the tumor-microenvironment interface. AST-BrM represents a distinct metastasis-associated astrocyte state, setting itself apart from homeostatic-like astrocytes. By mapping these states, we have uncovered two therapeutic targets: an AP-1-high axis and a STAT3+/HOPX+-associated axis.

Genetic and pharmacologic interventions have confirmed their functional relevance, and an AP-1/c-FOS-driven signature has been linked to clinical outcomes. In summary, this study provides a comprehensive understanding of conserved, spatially organized, and actionable astrocyte programs that drive brain metastasis progression, paving the way for targeted interventions.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at biorxiv.org →

Report a problem with this story

More in Health & Medicine

More from Tuesday 17 November →